Vito Annese Selected Research

Vito Annese Research Topics

Disease

43	Ulcerative Colitis 06/2022 - 04/2005
38	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 01/2005
27	Crohn Disease (Crohn's Disease) 06/2022 - 06/2005
11	Esophageal Achalasia (Megaesophagus) 01/2021 - 03/2004
9	Inflammation (Inflammations) 12/2020 - 11/2007
6	Colitis 09/2017 - 11/2007
4	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 08/2014
4	Neoplasms (Cancer) 10/2016 - 05/2007
3	Disease Progression 03/2019 - 12/2013
3	Rheumatoid Arthritis 11/2014 - 11/2009
2	Pancreatitis 10/2014 - 04/2007
2	Necrosis 09/2014 - 02/2007
2	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2014 - 01/2014
2	Infections 01/2011 - 01/2011
1	Esophageal Diverticulum 11/2022
1	Dysbiosis 06/2022
1	Neoplasm Metastasis (Metastasis) 03/2019
1	Fibrosis (Cirrhosis) 12/2017
1	Chronic Hepatitis C 12/2017
1	Leukemia 10/2016
1	Adenoma (Adenomas) 07/2016
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2015
1	Hypersensitivity (Allergy) 09/2015
1	Diarrhea 06/2015
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 06/2015
1	Back Pain (Backache) 11/2014
1	Ankylosing Spondylitis 11/2014

Drug/Important Bio-Agent (IBA)

13	SteroidsIBA 01/2021 - 04/2005
8	Pharmaceutical PreparationsIBA 01/2017 - 04/2007
8	Proteins (Proteins, Gene)FDA Link 10/2016 - 11/2007
7	Infliximab (Remicade)FDA Link 01/2021 - 08/2008
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 04/2005
6	CytokinesIBA 06/2015 - 06/2009
5	Prednisone (Sone)FDA LinkGeneric 01/2019 - 06/2011
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 02/2007
4	Biological ProductsIBA 12/2020 - 08/2014
4	Biosimilar PharmaceuticalsIBA 01/2019 - 11/2014
4	Mesalamine (Mesalazine)FDA LinkGeneric 01/2016 - 04/2005
4	Beclomethasone (Beclometasone)FDA Link 06/2015 - 04/2005
3	Immunoglobulin G (IgG)IBA 12/2020 - 01/2018
3	Adalimumab (Humira)FDA Link 01/2019 - 01/2011
3	DNA (Deoxyribonucleic Acid)IBA 03/2017 - 02/2009
3	Immunosuppressive Agents (Immunosuppressants)IBA 02/2016 - 10/2010
3	Interleukin-23 (Interleukin 23)IBA 01/2014 - 05/2007
2	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2018
2	2-mercaptopurineIBA 01/2019 - 10/2014
2	Messenger RNA (mRNA)IBA 09/2017 - 12/2013
2	CT-P13IBA 01/2017 - 01/2017
2	Amino Acids FDA Link 01/2016 - 08/2014
2	ChemokinesIBA 06/2015 - 05/2007
2	Azathioprine (Imuran)FDA LinkGeneric 10/2014 - 11/2009
2	Monoclonal AntibodiesIBA 08/2014 - 01/2014
2	HLA-DQ Antigens (HLA-DQ)IBA 08/2014 - 08/2007
2	Interleukin-33IBA 04/2014 - 01/2013
2	Interleukin-12 (IL 12)IBA 01/2014 - 03/2009
2	Substance PIBA 12/2013 - 06/2012
2	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2013 - 05/2007
2	LigandsIBA 01/2012 - 05/2007
2	Certolizumab Pegol FDA Link 01/2009 - 08/2008
2	myosin IXBIBA 05/2007 - 12/2006
1	Volatile Fatty AcidsIBA 06/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2018
1	Protons (Proton)IBA 12/2017
1	Complement System Proteins (Complement)IBA 06/2017
1	Genetic Markers (Genetic Marker)IBA 04/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2017
1	AntioxidantsIBA 01/2017
1	Tight Junction ProteinsIBA 10/2016
1	Claudin-2IBA 10/2016
1	Vitamin D FDA LinkGeneric 10/2016
1	Methotrexate (Mexate)FDA LinkGeneric 10/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2016
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2016
1	InterleukinsIBA 09/2015
1	Deoxyribonucleases (DNase)FDA Link 09/2015
1	MicroRNAs (MicroRNA)IBA 09/2015
1	InterferonsIBA 09/2015
1	InflammasomesIBA 06/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2015
1	Coloring Agents (Dyes)IBA 03/2015
1	HLA-DRB1 Chains (HLA DRB1)IBA 02/2015
1	Complementary DNA (cDNA)IBA 01/2015
1	Capsules (Microcapsules)IBA 12/2014
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 11/2014
1	MucinsIBA 10/2014
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 10/2014
1	A 17 (A-17)IBA 10/2014

Therapy/Procedure

26	Therapeutics 11/2022 - 04/2005
6	Heller Myotomy 01/2021 - 03/2004
5	Biological Therapy 01/2021 - 01/2011
3	Myotomy 11/2022 - 03/2004
3	Blood Component Removal (Apheresis) 01/2019 - 01/2013
3	Colectomy 01/2016 - 12/2013
2	Fundoplication 05/2011 - 03/2004
1	Polypharmacy 11/2019
1	Aftercare (After-Treatment) 03/2019